Sudan I/BSA is an antigen-adjuvant conjugate composed of Sudan I and bovine serum albumin (BSA). Conjugating the antigen with a protein adjuvant can boost the production of antigen-specific antibodies in vaccine models. This conjugate does not affect protein folding or disrupt primary epitopes, and it enhances cross-presentation and the generation of antigen-specific T cells.